Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystis
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2021-06-01
|
Series: | mSphere |
Online Access: | https://journals.asm.org/doi/10.1128/mSphere.01144-20 |
id |
doaj-f0f0b4cd8cad40f0b7cab1d5bb3c5cd3 |
---|---|
record_format |
Article |
spelling |
doaj-f0f0b4cd8cad40f0b7cab1d5bb3c5cd32021-09-21T20:35:24ZengAmerican Society for MicrobiologymSphere2379-50422021-06-016310.1128/mSphere.01144-20Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in MiceGuixiang Dai0Kristin Noell1Gisbert Weckbecker2Jay K. Kolls3https://orcid.org/0000-0001-5151-6304Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USACenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USANovartis, Basel, SwitzerlandCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystishttps://journals.asm.org/doi/10.1128/mSphere.01144-20 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Guixiang Dai Kristin Noell Gisbert Weckbecker Jay K. Kolls |
spellingShingle |
Guixiang Dai Kristin Noell Gisbert Weckbecker Jay K. Kolls Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice mSphere |
author_facet |
Guixiang Dai Kristin Noell Gisbert Weckbecker Jay K. Kolls |
author_sort |
Guixiang Dai |
title |
Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice |
title_short |
Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice |
title_full |
Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice |
title_fullStr |
Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice |
title_full_unstemmed |
Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice |
title_sort |
effect of subcutaneous anti-cd20 antibody-mediated b cell depletion on susceptibility to pneumocystis infection in mice |
publisher |
American Society for Microbiology |
series |
mSphere |
issn |
2379-5042 |
publishDate |
2021-06-01 |
description |
Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with
PneumocystisPneumocystis |
url |
https://journals.asm.org/doi/10.1128/mSphere.01144-20 |
work_keys_str_mv |
AT guixiangdai effectofsubcutaneousanticd20antibodymediatedbcelldepletiononsusceptibilitytopneumocystisinfectioninmice AT kristinnoell effectofsubcutaneousanticd20antibodymediatedbcelldepletiononsusceptibilitytopneumocystisinfectioninmice AT gisbertweckbecker effectofsubcutaneousanticd20antibodymediatedbcelldepletiononsusceptibilitytopneumocystisinfectioninmice AT jaykkolls effectofsubcutaneousanticd20antibodymediatedbcelldepletiononsusceptibilitytopneumocystisinfectioninmice |
_version_ |
1717372142456143872 |